GRUENDEL PARTNER

Comment: In the wake of its rapid growth in 2015 and 2016, this recommended firm in Sachsen is now in the process of leveraging its newly won business and the potential that comes with it. Although transaction and financing advice remain the firm’s backbone despite its personnel and disciplinary expansion, the new full-service line-up offers opportunities that were previously unavailable. There have been tangible initial achievements, esp. in real estate transactions, in which the firm combined its corporate competence with the new expertise in real estate and tax. Gruendel now offers comprehensive advice on real estate issues. IT also continues to be a growing trend: alongside the established client base, it has become a significant focus for the firm, namely in advice to tech-savvy startup investors and their venture capital companies.
Strengths: Extensive experience in investments and with transactions/VC.
Development potential: The newly assembled team can already point to several successes. However, it will take time to convince sceptics in the Leipzig legal market that the firm is more than a glorified office share. The key to its success will lie in concerted business development.
Recommended: Dr. Mirko Gründel (corporate), Ralph Schmidkonz (media/press), Steffen Tietze (employment), Frank Vennemann (real estate/corporate), Dr. Albrecht Tintelnot (administrative/real estate/corporate).
Practice: Focus: corporate/M&A, primarily venture capital advice (advice to VC companies and financiers) as well as real estate. Traditional emphasis on press and media. Also public procurement, energy and employment. In Jena: public procurement, IP, IT. In addition, a small VC-focused office in Berlin. (Leipzig: 8 equity partners, 1 salary partner, 7 associates, 2 of counsel; Jena: 3 partners, 1 associate)
Clients: ?? Avedo on purchase of Vocando; WMS/S-UBG on investment and growth finance on the part of IT-Service GmbH; ongoing advice to Bm-t on acquisition of shares, financing and exits (incl. €31m financing round of InflaRX); ongoing advice to TGFS fund on acquisition of shares and exits (incl. Rhebo, Heliatek, Webdata); ongoing advice to GP Papenburg Hochbau on project developments.
  • Teilen